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Abstract
Signaling by fibroblast growth factor 10 (FGF10) through FGFR2b is essential for lung development. Heparan sulfates (HS) are major
modulators of growth factor binding and signaling present on cell surfaces and extracellular matrices of all tissues. Although recent studies
provide evidence that HS are required for FGF-directed tracheal morphogenesis in Drosophila, little is known about the HS role in
FGF10-mediated bud formation in the vertebrate lung. Here, we mapped HS expression in the early lung and we investigated how HS
interactions with FGF10–FGFR2b influence lung morphogenesis. Our data show that a specific set of HS low in O-sulfates is dynamically
expressed in the lung mesenchyme at the sites of prospective budding near Fgf10-expressing areas. In turn, highly sulfated HS are present
in basement membranes of branching epithelial tubules. We show that disrupting endogenous gradients of HS or altering HS sulfation in
embryonic lung culture systems prevents FGF10 from inducing local responses and markedly alters lung pattern formation and gene
expression. Experiments with selectively sulfated heparins indicate that O-sulfated groups in HS are critical for FGF10 signaling activation
in the epithelium during lung bud formation, and that the effect of FGF10 in pattern is in part determined by regional distribution of
O-sulfated HS. Moreover, we describe expression of a HS 6-O-sulfotransferase preferentially at the tips of branching tubules. Our data
suggest that the ability of FGF10 to induce local budding is critically influenced by developmentally regulated regional patterns of HS
sulfation.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Heparan sulfate proteoglycans (HSPG) represent a diverse
group of macromolecules widely expressed throughout tissues
in association with cell surfaces and extracellular matrices
(reviewed in Perrimon and Bernfield, 2000; Ornitz, 2000).
Heparan sulfates (HS) are characterized by a variable number
of repeating units of disaccharides containing uronic acid and
glucosamine residues which can be N-sulfated, N-acetylated,
and O-sulfated at three positions by at least 18 biosynthetic
enzymes (Lindahl et al., 1998; Aikawa et al., 2001). Genetic
studies in Drosophila and in mice implicate these enzymes and
their HS biosynthesis products in regulation of growth factor
signaling in a variety of developmental processes (Forsberg
and Kjellen, 2001). It has been proposed that HS facilitate FGF
signal transduction by stabilizing FGF/FGFR complexes and
by promoting oligomerization of FGF molecules at the cell
surface, increasing local ligand concentration (Ornitz, 2000).
Furthermore, studies on FGF2 show that HS promote FGF2
internalization, processing, nuclear localization, and inhibition
of degradation (Nugent and Iozzo, 2000; Sperinde and Nugent,
2000). Unique heparan sulfate structures have been shown to
differentially control receptor binding and activities of the
various FGFs. For example, heparin and HSPG preparations
that enhance the interaction of FGF1 with FGFR1 inhibit
FGF7 activities (Bonneh-Barkay et al., 1997; Berman et al.,
1999). FGF association with specific HS diferentially regulates
proliferation versus migratory activity in breast cancer cells
(Nurcombe et al., 2000). Binding of FGF2 and FGF4 is dif-
ferentially regulated by tissue-specific HS (Allen et al., 2001).
FGF signaling is critical for epithelial morphogenesis in
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developing branching structures. The branching pattern of
the tracheal tubules of Drosophila is established by expres-
sion of the FGF branchless (Bnl) in clustered cells outside
the epithelium at prospective sites of budding. Bnl activates
an FGFR, breathless (Btl), expressed in tracheal epithelial
cells, which then migrates and elongates toward the Bnl-
expressing cells to form a bud (Sutherland et al., 1996).
Recent studies have provided direct evidence that HS are
required for FGF-directed developmental processes in Dro-
sophila (Lin et al., 1999; Toyoda et al., 2000; Kamimura et
al., 2001). Loss-of-function of the HS biosynthetic enzymes
sulfateless and sugarless markedly reduces FGF-dependent
MAPK activation and disrupts tracheal branching (Lin et
al., 1999). Besides FGFs, HSPGs interact with and modu-
late activity of a number of other diffusible molecules,
including heparin binding growth factors, Hedgehogs,
Wingless, and protease inhibitors (Binari et al., 1997;
Umeda et al., 2001; Bellaiche et al., 1998).
Lung morphogenesis depends on the coordinated inter-
action of epithelial and mesenchymal signals, including
FGF, Sonic hedgehog (Shh), and TGF- family members
and their receptors (reviewed in Hogan, 1999; Warburton et
al., 2000; Cardoso, 2001). In the developing mouse lung, a
mechanism involving FGF10 and FGFR2 plays a role in
airway branching reminiscent of that described for branch-
less and breathless in Drosophila (Sutherland et al., 1996).
Fgfr2 is expressed throughout the respiratory tract epithe-
lium from the earliest stages of lung development and dur-
ing branching morphogenesis. The mesenchyme expresses
Fgf10 in a localized fashion in close association with distal
epithelial tubules. Moreover, expression of Fgf10 is dy-
namic; it seems to precede bud formation and is downregu-
lated once the bud is formed. The mechanisms by which
FGF10–FGFR2 signaling promotes epithelial budding in-
volve chemoattraction and cell proliferation (Bellusci et al.,
1997; Cardoso et al., 1997; Park et al. 1998; Weaver et al.,
2000). In Fgf10 or Fgfr2 knockout mice, lungs do not form
(Min et al., 1998; Sekine et al., 1999; De Moerlooze et al.,
2000).
Little is known about how HS influence FGF10-medi-
ated lung morphogenesis. To address this issue, we mapped
sites of HS expression, we disrupted HS formation or al-
tered the profile of HS sulfation in lung cell and organ
culture systems, and we studied the effects on the pattern of
growth and on gene expression of the lung epithelium. Our
data show a dynamic pattern of expression of a specific set
of low-O-sulfated HS in the mesenchyme during branching.
We found that O-sulfation of epithelial HS dramatically
influences the response of the epithelium to FGF10. More-
over, our data suggest that 6-O-sulfated HS are likely in-
volved in this process, since we identified developmentally
regulated expression of a heparan sulfate 6-O-sulfotrans-
ferase (HS 6-OST1) in the distal lung at sites of budding.
Our study supports the idea that the critical role of HS-FGF
interactions in Drosophila tracheal morphogenesis has been
conserved in the mammalian lung.
Materials and methods
Binding assays in 20-3 cells
Equilibrium binding of FGF10 and FGF7 to HS and
receptor sites on 20-3 lung epithelial cells was carried out
essentially as we described with FGF2 (Fannon et al., 2000).
125I-FGF10 and 125I-FGF7 were prepared by using a mod-
ification of Bolton-Hunter method to a specific activity of
25–75 Ci/g. Confluent 20-3 cultures were generated by
plating 5  104 cells/2-cm2 well in 24-well plates in 1 ml
DMEM containing 10% calf serum and penicillin (100
units/ml) and streptomycin (100 g/ml). Binding assays
were performed 3 days after cell plating. Cells were washed
once with 1 ml/well binding buffer (DMEM, 25 mM Hepes,
0.05% gelatin) at 4°C for 10 min to inhibit receptor endo-
cytosis. 125I-FGF10 or 125I-FGF7 was added at a range of
concentrations (4–90 ng/ml), and cells were incubated at
4°C for 2.5 h. At the end of the binding period, cells were
placed on ice and washed three times with ice-cold binding
buffer. HSPG-bound 125I-FGF10 or 125I-FGF7 was re-
moved with a quick wash (5 s) using 2 M NaCl in 20 mM
Hepes, pH 7.4, followed by a wash with PBS. Cell surface
receptor-bound 125I-FGF10 or 125I-FGF7 was subsequently
extracted with two washes (one 5 min and one rapid wash)
at room temperature using 2 M NaCl in 20 mM sodium
acetate, pH 4.0. Nonspecific binding was measured and
subtracted from all data.
MAPK and Akt phosphorylation
Phosphorylation of MAP-kinase and Akt were measured
as indicators of FGF signaling pathway activation in hepa-
rinase III or sodium chlorate-treated cells stimulated with
FGF10 or FGF7. Cultured embryonic rat lung epithelial
cells (20-3 cell line) were treated with heparinase III (hep,
50 mU/ml) or sodium chlorate (NaChl, 25 mM) for 30 min
and then stimulated with FGF7 (5 ng/ml) or human recom-
binant FGF10 (5 ng/ml) (R&D Systems) for 10 min. After
the stimulation, cells were washed with PBS and lysed in
RIPA cell lysis buffer. Proteins were resolved on 7.5%
SDS–PAGE and analyzed by Western blotting with anti-
phospho-Akt, anti-phospho-MAPK, Akt, and MAPK anti-
bodies (all from New England BioLabs, Beverly, MA).
Results were compared with those of cells without hepari-
nase III or sodium chlorate treatment.
Epithelial cultures
Mesenchyme-free epithelial cultures were isolated and
cultured as described elsewhere (Nogawa and Ito, 1995).
Briefly, E11.5 lungs were placed into Dispase solution for
20 min at 37°C. Epithelial rudiments were microdissected
from the mesenchyme, covered with 50 l of Matrigel (BD
Biosciences) and 400 l of DMEM containing human re-
combinant FGF10 (2500 ng/ml) or FGF7 (500 ng/ml) (R&D
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Systems). Epithelium was incubated at 37°C for 48 h. Cul-
tures were fixed overnight in 4% paraformaldehyde at 4°C
and processed for either in situ hybridization or immuno-
histochemical analysis.
Whole lung cultures
E11.5 mouse lungs were dissected and placed on Milli-
pore 0.8-m filters on the top of metal meshes in 60-mm
organ culture dishes (Fisher Scientific). Lungs were cul-
tured for 24–48 h in BGJb media (Gibco BRL), containing
1% fetal calf serum (Gibco BRL) and 20 mg/ml vitamin C
(Sigma) (Park et al., 1998). In some experiments, heparin
beads soaked in recombinant FGF10 (100 ng/l) (R&D
Systems) were grafted onto E11.5 lungs that were cultured
for up to 72 h. Specimens were fixed in 4% paraformalde-
hyde at 4°C overnight. For in situ hybridization experi-
ments, specimens were dehydrated by washing in increasing
concentration of methanol in PBS and stored at 20°C in
100% methanol. For immunohistochemical analysis, speci-
mens were processed into paraffin.
Modified heparins, heparinase III, and sodium chlorate
Modified heparins were obtained from Neoparin Inc.
(San Leandro, CA), and all had an average molecular
weight of 13 kDa. In over-O-sulfated (or fully-O-sul-
fated) heparin (overOS), all primary hydroxyls in glu-
cosamine residues and a large proportion of secondary
hydroxyl groups in disaccharide units were substituted
by O-sulfated esters. De-O-sulfated heparin (deOS) is a
derivative in which all O-sulfate esters were removed
while preserving N-sulfates. In 6-O-desulfated heparins
(6deOS), all O-sulfate groups on C-6 of glucosamine
residues have been removed while most of the 2-O-
sulfate groups (90%) and 3-O-sulfate groups remain
intact. In 2-O-desulfated heparins (2deOS), all O-sulfate
groups on C-2 of uronic acid residues have been re-
moved. All modifications did not affect the amino groups
of glucosamine residues or the backbone structure of the
derivative. Heparins were dissolved in PBS and added to
the media in whole lung and epithelial cultures to final
concentrations ranging from 25 to 125 g/ml. To block
HS sulfation, we used sodium chlorate to inhibit the
generation of PAPS, the natural donor of sulfate groups
necessary for HS modifications. For whole lung cultures
or epithelial cultures, 25 mM sodium chlorate was added
to the media. This concentration has been shown to
drastically reduce the number of sulfate groups of glu-
cosaminoglycan (GAG) residues in HS (Humphries and
Silbert, 1988; Safaiyan et al. 1999); preliminary experi-
ments showed that toxicity is not observed within the
range of 25–50 mM concentration (data not shown).
Heparinase III from Flavobacterium heparinum (E.C.
4.2.2.8, Biomarin Pharmaceuticals Inc., Montreal, Can-
ada) was used to digest HS in cultured lungs at concen-
trations of 50 mU/ml, as previously established by others
(Toriyama et al., 1997). Medium was changed daily in all
culture systems.
Whole-mount in situ hybridization
DIG-labeled sense and antisense RNA probes were ob-
tained by using SP6 or T3/T7 Maxi Script kits (Ambion
Inc.). DIG, proteinase K, blocking reagent, anti-dioxige-
nin-AP Fab fragment, and BM purple precipitating AP
substrate were from Roche Diagnostics. Whole lung ex-
plants were pretreated with 14 mg/ml proteinase K for 10
min, prehybridized for 1 h at 70°C, and hybridized with
RNA probes overnight at 70°C in buffer containing 50%
formamide, 5 SSC, 1% SDS, 50 mg/ml yeast tRNA, and
50 g/ml heparin (Sigma). Specimens were pretreated with
blocking solution containing 2% blocking reagent and 10%
sheep serum and incubated with anti-digoxigenin-AP Fab
fragment and 2% sheep serum overnight at 4°C. Signals
were visualized by using BM purple according to manufac-
turer’s protocol. We assessed expression of Sp-C (Cardoso
et al., 1997), Fgf10, and Bmp4 (cDNA clones kindly pro-
vided by Dr. Andrew P. McMahon, Harvard Biolabs) as in
Lebeche et al. (1999). To generate probes for HS 6-OST1,
total RNA from E12 mouse lung was reverse transcribed
and PCR amplified by using primers designed from known
GenBank sequences (HS 6-OST1: GI6683559). PCR prod-
uct was verified by sequencing and cloned. Probes were
obtained by using Maxi Script kits as above.
Antibodies
HS distribution was visualized by using anti-heparan
sulfate mouse monoclonal antibodies 10E4 and 3G10
(“anti-stub”) obtained from Seikagaku Inc. The 10E4 anti-
gen has been traditionally used as a marker of native HS
chains with low content of O-sulfates in a variety of devel-
oping tissues (David et al., 1992; Bai et al., 1994). A recent
analysis of the 10E4 antigen by mass spectrometry revealed
that it possibly contains nonsulfated heparan motifs with
unusual unsubstituted glucosamine residues (Leteux et al.,
2001). 10E4 reactivity is abolished by treatment with bac-
terial heparinase III [0.5 units/ml in PBS containing sodium
and magnesium chloride (Sigma) for 30 min at 37°C]. Only
staining sensitive to heparinase III treatment was considered
to represent heparan sulfate. HSPG core proteins were de-
tected in lung sections by using the 3G10 antibody, which
recognizes a neo-epitope generated on HSPG by heparinase
III digestion (400 mU/ul for 2 h). This epitope consists of
desaturated uronate residues, most likely an N-acetylated
glucosamine. 3G10 maps sites where HS are present, but it
does not provide information about HS modifications
(David et al., 1992)
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Immunohistochemical analysis
For analysis of paraffin sections, the anti-mouse IgG
kits from Vector Laboratories were used according to
manufacturer’s protocol. Whole-mount immunohisto-
chemical analysis of E10.5–E13 mouse lungs was per-
formed as described (Hogan et al., 1994). Patterns were
visualized by using the DAB staining kit (Vector Labo-
ratories). To capture gradients of 10E4 expression in
whole mounts, we diluted the primary antibody to 1–5
g/ml and we decreased incubation time in substrate for
color development, so that only areas with the highest HS
levels were labeled.
Alcian blue staining
We used a modified Alcian blue staining protocol in which
aluminum sulphate is added to selectively detect highly sul-
fated components of the extracellular matrix in paraformalde-
hyde fixed tissues (Heath, 1961). Paraffin sections of cultured
whole lungs (48 h) were rehydrated and stained in solution
containing 0.5 g aluminum sulfate and 1 g Alcian blue in 100
ml of distilled water for 6 h at room temperature. Chondroiti-
nase ABC (Seikagaku Inc.) (100 mU/ml, 2 h, 37°C) or hepa-
rinase III (400 mU/ml, 2 h, 37°C) pretreatment was used to
digest chondroitin sulfates or HS, respectively (Heath, 1961).
Sections were counterstained with Fast Red.
Fig. 1. (A) Binding of FGF10 to HSPG is increased when compared with FGF7 in confluent 20-3 lung epithelial cells; however, binding to FGFR2 is similar
for both FGFs (see Materials and methods). Data represent the average of triplicate determinations. (B) Western blot analysis of 20-3 lung epithelial cells
stimulated with recombinant FGF7 or FGF10 (both at 5 ng/ml, 10 min) before (control) and after sodium chlorate (NaChl) or heparinase III (hep) treatment.
MAPK phosphorylation is stimulated at equal levels by FGF7 or FGF10 in controls. Under the same conditions, Akt is not phosphorylated. Heparinase III
or NaChl treatment does not block MAPK phosphorylation by FGF7 but attenuates that by FGF10 (B, representative blot of n  3 determinations).
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Cell proliferation assay
We assessed cell proliferation in situ by immuno-
histochemical detection of Proliferation Cell Nuclear
Antigen (PCNA staining kit; Zymed) in paraffin sec-
tions of E11.5 lung treated with modified heparins
for 48 h (above) according to the manufacturer’s instruc-
tions.
Fig. 2. Modified heparins modulate the epithelial response to FGF10. Mesenchyme-free epithelial explants cultured in FGF10 (2500 ng/ml; A–H) or FGF7
(500 ng/ml; I, J) containing media for 48 h. (A) Bud formation in FGF10-treated epithelial cultures (2500 ng/ml, 48 h). Culturing explants in media containing
(B) FGF10 plus heparinase III (50 mU/ml) results in tissue death. (C) Pretreatment of explants with heparinase III for 30 min (50 mU/ml) followed by
culturing in FGF10-containing medium (no heparinase) does not disrupt budding, suggesting quick reconstitution of HS moieties. (D) Cultures treated with
FGF10 plus NaChl (25 mM) die within 24 h. (E) De-O-sulfated heparin does not rescue FGF10 signaling in the presence of NaChl, but (F) addition of
over-O-sulfated, (G) 2-O-desulfated, or (H) 6-O-desulfated heparins results in the formation of cyst-like structures. In situ hybridization of Bmp4 in (A)
control FGF10 cultures show diffuse low levels of expression (red arrow) after 48 h; yellow arrow depicts proximal, nonexpressing area. A dramatic
upregulation of Bmp4 expression is induced by FGF10 in the presence of O-modified heparins (F–H). (I, J) FGF7 induces cystic growth and strong Bmp4
expression in the epithelium, comparable with that induced by FGF10 with O-modified heparins. (J) The FGF7 effects are not altered by NaChl. All modified
heparins at 125 g/ml; results are representative of at least four to five explants per experimental condition. Bars represent 200 m.
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Results
HS bind FGF10 and influence FGF10–FGFR2 signaling
in the lung epithelium
We examined the ability of HS from lung epithelial cells
to bind to FGF10 and modulate FGF signaling. Binding
assays were performed in a lung epithelial cell line by using
radiolabeled ligand and varying ionic strength and pH con-
ditions to determine the proportion of ligand bound to cell
surface receptor and to HS (Fannon et al., 2000). We used
20-3, an epithelial cell line derived from rat fetal lungs
which expresses FGFR2b and HSPG (data not shown) and
responds to FGF10. Results in Fig. 1A indicate that FGF10
binds to HS on 20-3 cells to a significantly greater extent
than to FGFR2b as evident by an10-fold greater maximal
number of binding sites. Experiments were similarly per-
formed by using radiolabeled FGF7 for comparison. FGF7
and FGF10 show a high degree of sequence homology; both
signal through FGFR2b and are present in the developing
lung mesenchyme (Igarashi et al., 1998; Bellusci et al.,
1997). We found that 20-3 cells contain approximately
seven times more HS binding sites for FGF10 than for
FGF7. Furthermore, ligand intercompetition experiments
reveal no competition of 125I-FGF10 binding to HSPG by
FGF7, while unlabeled FGF10 was only able to compete for
15% of the binding of 125I-FGF7 to HSPG on 20-3 cells.
Our data indicate the presence of specific HS binding sites
for FGF10 on these cells and suggest that HSPG may be
critical for FGF10 interactions in the lung epithelium.
We then tested whether activation of FGFR2 signaling
by FGF10 or FGF7 in lung epithelial cells is differentially
regulated by HS and HS sulfation. Previous studies have
shown that, in L6E9 and Balb/MK cells, heparin enhances
FGFR2 binding and mitogenic activity of FGF1 but inhibits
those of FGF7 (Reich-Slotky et al., 1994). We monitored
levels of MAPK and Akt phosphorylation in 20-3 cells
cultured in FGF10 or FGF7 before and after treatment with
bacterial heparinase III or NaChl (Fig. 1B). MAPK and Akt
phosphorylation have been associated with FGF-induced
cell proliferation and migration. Heparinase III digests
GAG side chains, and NaChl inhibits HSPG sulfation
(Safaiyan et al., 1999). Fig. 1B shows that MAPK phos-
phorylation is stimulated at equal levels by both FGFs
within 10 min when cell surface HS are intact (control).
Disruption of HS or preventing its sulfation does not block
activation of FGF signaling by any of these FGFs; however,
it markedly attenuates phosphorylation of MAPK by
FGF10. The Akt pathway does not seem to be affected by
FGF treatment under these conditions.
Our data led us to conclude that the presence of cell
surface HS and adequate levels of GAG sulfation, although
not absolutely required to initiate FGF10–FGFR2 signaling,
may be necessary to efficiently transduce signals and me-
diate some of the FGF10 responses under physiological
conditions.
HS sulfation modulates the response of the lung
epithelium to FGF10
To investigate the role of HS in FGF10-induced budding
in the absence of other HS-dependent signals likely present
in the lung mesenchyme, we used embryonic lung epithelial
cultures. E11.5 mesenchyme-free epithelial explants were
cultured in serum-free medium containing recombinant
FGF10 with or without heparinase III or NaChl. Recombi-
nant FGF10 has been shown to induce bud formation in
lung epithelial cultures (Fig. 2A; Bellusci et al., 1997; Park
et al., 1998). We observed that culturing explants in FGF10-
containing medium plus heparinase III (50 mU/ml) or
NaChl (25 mM) results in death within 24 h (Fig. 2B and
D). The effect on survival is similar to that observed when
no FGF is added to the medium, which suggests that, under
these conditions, FGF signaling is disrupted. Cultures can-
not be rescued by increasing FGF10 concentrations to as
high as 5000 ng/ml. However, without heparinase III, HS
moieties seem to be rapidly reconstituted on the surface of
lung epithelial cells. If explants are pretreated with hepari-
nase III (50 mU/ml, 30 min at 37°C), washed in buffer, and
then cultured in FGF10-containing medium, generalized
budding occurs as in control conditions (Fig. 2C).
To further analyze the role of HS sulfation on FGF-
induced budding, we checked whether providing selectively
sulfated GAGs could replace endogenous HS and rescue
NaChl-treated cultures. We used chemically modified hep-
arin derivatives in which defined sulfate groups were either
added or deleted to generate de-O-sulfated, over-O-sulfated,
2-O-desulfated, or 6-O-desulfated heparins (see description
in Materials and methods). These compounds have been
used in a number of studies to assess the role of specific HS
structures in developmental processes (Irie et al., 2002;
Rubin et al., 2002; Yip et al., 2002). We cultured E11.5 lung
epithelial explants in medium containing FGF10 (2500 ng/
ml) plus NaChl (25 mM) with or without heparins (25–125
g/ml) for 48 h. Morphological growth and gene expression
were assessed and compared with controls cultured in
FGF10 alone (2500 ng/ml) (Fig. 2A). Concentrations were
shown to be effective and nontoxic from preliminary exper-
iments and from data by others (Yip et al., 2002; Irie et al.,
2002).
Addition of de-O-sulfated heparin, which has N-sulfate
but lacks O-sulfate groups, does not rescue FGF10 signaling
at any concentration, and cultures die within 24 h (Fig. 2E).
The effect is similar to that of NaChl treatment alone (Fig.
2D). This supports the idea that sulfated GAGs, other than
O-modified, are not able to efficiently interact with FGF10
to modulate binding to FGFR2 and activate downstream
responses. Supplementation with a fully O-sulfated heparin
allows FGF-mediated survival and growth in the presence
of NaChl, but results in a phenotype strikingly different
from that of a typical FGF10-treated culture. Rather than
budding, FGF10 induces generalized growth and formation
of cyst-like structures (Fig. 2F). The effect on growth is
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similarly observed when cultures are supplemented with
2-O- or 6-O-desulfated heparins (Fig. 2G and H). Our data
in epithelial cultures suggest that the ability of FGF10 to
induce localized budding in the absence of an FGF gradient
is likely a function of local expression of sulfated GAGs in
HS, presumably at the bud tips. This is based on the obser-
vation that disrupting local endogenous gradients of sulfated
GAGs with NaChl and replacing them with sulfated heparin
in a generalized fashion prevents FGF10 from inducing
local responses.
Selectively sulfated heparins in FGF-mediated induction
of gene expression
We tested the ability of synthetic heparins to induce
expression of Bmp4, a known FGF10 target gene (Lebeche
et al., 1999, Weaver et al., 2000). In the E11.5 lung, Bmp4
is expressed at the tip bud epithelium near Fgf10-expressing
mesenchymal cells (Bellusci et al., 1997; Lebeche et al.,
1999). Whole-mount in situ hybridization analysis of
FGF10-treated epithelial cultures shows low levels of Bmp4
diffusely expressed in the explant, in agreement with a
previous report (Fig. 2A; Ohtsuka et al., 2001). By contrast,
Bmp4 signals are dramatically increased in FGF10/NaChl-
treated cultures supplemented with O-sulfated heparins
(Fig. 2F–H). Bmp4 appears to be upregulated at comparable
levels by all O-sulfated heparins. This suggests that lack of
2-O- or 6-O-sulfated GAGs in selectively desulfated hepa-
rins is compensated by other sulfated GAG groups, at least
within the range of concentrations tested. Likely, these
compensatory mechanisms also take place in vivo and ex-
plain why genetic inactivation of several individual specific
sulfotransferases in mice does not result in a dramatic effect
on branching (Forsberg and Kjellen, 2001).
Interestingly, we found that, by replacing endogenous
gradients of HS sulfation in FGF10 –NaChl-treated cul-
tures with O-sulfated heparins, it is possible to ubiqui-
tously activate FGFR2 signaling and reproduce the FGF7
effect in pattern and gene expression. Fig. 2I shows that
FGF7 alone (500 ng/ml) induces generalized growth and
Bmp4 expression in lung epithelial explants (Cardoso et
al., 1997; Bellusci et al., 1997). This phenotype is virtu-
ally identical to that of FGF10-treated cultures shown in
Fig. 2F–H. Moreover, in agreement with our data in 20-3
cells, we found that FGF7 does not seem to require
O-sulfated HS to bind to and activate FGFR2 signaling in
the epithelium. Viability, growth, and Bmp4 expression
are preserved in these cultures under NaChl treatment (25
mM) at a concentration that resulted in death of FGF10
explants (Fig. 2J). Taken together, these results suggest
that O-sulfated groups are critical for HS–FGF10 –
FGFR2 interactions during bud formation and that the
effect of FGF10 in pattern is modulated, at least in part,
by regional distribution of O-sulfated HSPG.
HS requirement for branching and FGF10-induced
responses
We examined how altering endogenous HS and HS-
dependent pathways affects branching morphogenesis in
intact lung cultures. We cultured E11.5 lung explants for
72 h in control BGJb medium alone or in medium contain-
ing heparinase III (50 mU/ml) or NaChl (25 mM). Treat-
ment with NaChl (48 h) was preceded by a 24-h heparinase
III treatment. To determine whether these conditions inter-
fered with previously reported FGF10 effects in epithelial
morphogenesis, we implanted FGF10-soaked beads onto
these lungs. Under control conditions, branching morpho-
genesis occurs normally, except in areas where exogenous
FGF10 redirects growth of distal epithelial buds toward the
bead (Fig. 3A; Park et al., 1998; Weaver et al., 2000). In
heparinase III-treated lungs, branching is disrupted and
lungs are smaller overall than controls (Fig. 3B). This sug-
gests that the relative deficiency in HS cannot be compen-
sated by endogenous FGF10, resulting in decreased branch-
ing. Heparinase III did not interfere with endogenous Fgf10
expression as assessed by in situ hybridization (Fig. 3D and
E, right panels). We found that distal epithelial buds can still
respond to high levels of exogenous FGF10 by encircling
the bead. Thus, excess ligand supplied by the bead locally
overcomes the HS deficiency to induce a proper epithelial
response. Explants cultured in NaChl display a more severe
phenotype (Fig. 3C). Although some growth occurred, the
overall pattern of branching of NaChl-treated cultures was
reminiscent of that of the E11.5 uncultured lung. The effect
of NaChl in disrupting FGF10 signaling is demonstrated by
the failure of the epithelium to grow toward and engulf the
bead (Fig. 3C). These experiments suggest that the presence
of sulfate groups in HS is critical in mediating the FGF10
effects in bud morphogenesis.
Over-O-sulfation disrupts branching morphogenesis
in vitro
The studies in epithelial cultures (previous sections)
were performed in a system in which exogenous FGF10 was
ubiquitously available to the epithelium. Here, we analyzed
the effect of O-sulfation in lung pattern formation in the
context of naturally occurring gradients of FGF10, HS, and
other HS-dependent signals. Selectively modified heparins
have been used to compete with endogenous HSPG for
HS-binding molecules and alter patterning events (Irie et al.,
2002). We took a similar approach to study the HS role in
lung epithelial morphogenesis. For this, we cultured E11–
E12 lungs for 48 h in medium containing selectively sul-
fated heparins (25–125 g/ml). We limited our analysis to
heparins in which no O-sulfates (deOS) or the maximal
number of O-sulfates (overOS) were present. Fig. 4A de-
picts the pattern of branching of control cultures. Typically,
proximal lung shows tubules lined by a tall columnar epi-
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thelium, while distal tubules have a low cuboidal epithelium
which expresses the distal marker surfactant protein Sp-C
(Fig. 4D and E). Cultures treated with de-O-sulfated heparin
had little or no changes in morphology and gene expression
even at the highest concentration and were essentially sim-
ilar to controls (Fig. 4C, and data not shown). By contrast,
over-O-sulfated heparin disrupts branching at all concentra-
tions and induces formation of markedly enlarged airways
in the explant (Fig. 4B and G). Formation of typical Sp-C-
expressing distal tubules is markedly reduced, and most of
the explant consists of proximal-like hyperplastic columnar
epithelium (Fig. 4H). PCNA staining reveals increased la-
beling in areas of hypercellularity of distal buds as com-
pared with controls (Fig. 4I and F).
Lack or excess of O-sulfates prevents FGF10 activation
of Bmp4
To further investigate how lack (NaChl treatment) or
excess (overOS) of O-sulfates influenced FGF10 signaling
in whole lung cultures, we examined the effect of these
treatments in Bmp4 expression. Fig. 5 depicts typical dis-
tribution of Bmp4 and Fgf10 in the distal lung of 48-h
control cultures (Fig. 5A and B, left panel) and shows the
strong Bmp4 upregulation by exogenous FGF10 (Fig. 5C;
Lebeche et al., 1999; Weaver et al., 2000). Sodium chlorate
treatment nearly abolishes Bmp4 signals in these cultures,
suggesting that, under this condition, endogenous Fgf10 is
not being made or cannot bind to the epithelium to activate
signaling. Interestingly, Fgf10 availability does not seem to
be the limiting factor since strong mRNA signals are present
in the mesenchyme (Fig. 5A, middle panel). Moreover,
providing exogenous FGF10 in beads does not significantly
rescue Bmp4 in the epithelium (Fig. 5C, right panel) and
supports the idea that FGF10 binding to epithelium under
NaChl is impaired. Similarly, we found that Bmp4 was
greatly downregulated in cultures treated with over-O-sul-
fated heparin, despite abundant Fgf10 expression (Fig. 5A
and B, right panels). We postulated that, in this case, loss of
Bmp4 results from competitive binding and sequestration of
HS-dependent molecules that regulate branching morpho-
genesis, including Fgf10.
Taken together, our data indicate that properly O-sul-
fated HS are required for FGF10 binding and activation
of target genes in the lung epithelium. These conclusions
are further supported by data from binding assays using
a FGF10-specific antibody (Sakaue et al., 2002; Harada
et al., 2002), in these cultures (K.I. and W.V.C., personal
communication).
Fig. 3. Role of HSPG in branching morphogenesis. (A–C) Whole lung explants (E11.5) cultured in control (A) or heparinase III-containing media (50 mU/ml)
(B) for 72 h. (C) Whole lung explants cultured in the presence of heparinase III for 24 h followed by 48 h of treatment with NaChl (25 mM, no heparinase
III). FGF10-soaked beads were placed at distal and proximal sites in the lungs after 24 h. FGF10 is chemoattractant for distal but not proximal buds. Distal
epithelium surrounds FGF10 beads in control (A) and heparinase III-treated lungs (B), but not in NaChl-treated lungs (C). (D, E) Expression of Fgf10 mRNA
(arrowhead) is preserved in lung explant treated with heparitinase III for 24 h (E) compared with control (D).
Fig. 4. Effects of over-O-sulfated heparins on branching morphogenesis, Sp-C expression, and cell proliferation (PCNA). (A, D–F) Control 48-h cultures
showing typical proximal (pr) airways and distal (di) epithelial tubules (D) expressing Sp-C (E), with a normal pattern of PCNA labeling (F). (B, G–I)
Addition of over-O-sulfated heparin (125 g/ml) results in disruption of typical distal airways and formation of large, proximal-like tubules (B) lined by a
hyperplastic columnar epithelium (G) in which expression of Sp-C is disrupted (H) and cell proliferation is increased (I). De-O sulfated heparin has minimal
effects in branching, and cultures behave as controls (C, and data not shown). (A–C) Whole mounts; (D, G) hematoxilin & eosin. Bars represent 250 m
in (A) and 80 m in (G).
Fig. 5. (A–C) Whole-mount in situ hybridization of Fgf10 (A) and
Bmp4 (B, C) in lung explants cultured for 48 h in control (ctl) and
sodium chlorate (NaChl) or over-O-sulfated heparin (Over OS)-containing
media. Proper HS sulfation is required for FGF10 activation of its target
Bmp4 in distal epithelium. Bmp4 expression is inhibited by NaChl or
OverOS HS. (D) An FGF10-containing bead has been engrafted in control
and NaChl-treated cultures. In control, Bmp4 is upregulated by FGF10
(single and double arrows). Bmp4 is greatly downregulated in sodium
chlorate-treated cultures and is only minimally rescued by excess of FGF10
(arrow).
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Fig. 6. HS expression during branching morphogenesis. (A–C) Sections of 48-h control cultured lungs immunostained with (A) antibody 3G10 to show total
HS, or (B, C) stained with Alcian blue (AlcB) to show highly sulfated glycosaminoglycans (GAGs) (see Materials and methods). (A) HS staining by 3G10
is found in all layers but is stronger in basement membranes (arrow). (B) Strong Alcian blue staining is present in mesenchyme (yellow arrowhead) and
basement membrane. Signals are abolished by simultaneous treatment with chondroitinase ABC and heparinase III (not shown). Pretreatment with
chondroitinase ABC alone (C) results in weak staining in the mesenchyme (yellow arrowheads) and strong signals in basement membranes (black arrow).
(A–C) suggest the presence of abundant chondroitin sulfate and low-sulfated HS in the mesenchyme and highly sulfated HS in basement membrane. (D–H)
Immunostaining using 10E4 antibody to show areas of low sulfated HS. (D–F) Whole-mount control cultured lungs (E11.5  24 h) before (D) and after
heparinase III treatment (50 mU/ml for 1 h) (E). HS signals are present in mesenchyme associated with distal buds (D, arrowhead) and are extinguished by
heparinase III (E). (F) Negative control without primary antibody. (G, H) 10E4 immunostaining in sections of E11.5–E12 mouse lungs confirms high levels
of HS expression in distal (di) but not proximal (pr) mesenchyme. Bars represent 20 m (A), 100 m (E), and 60 m (H).
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HS are differentially sulfated in mesenchyme and
basement membrane of the lung
To gain insights into the profile of HS expression of the
developing lung during branching, we first stained sections of
embryonic lungs in vivo and in vitro with the 3G10 antibody.
This epitope reveals areas where HS are present regardless of
the pattern of HS modification (David et al., 1992). As shown
in Fig. 6A, 3G10 reactivity is present in both epithelium and
mesenchyme of branching airways; strong signals underlie
basement membranes. To localize areas of highly sulfated
GAGs, including those in HS and chondroitin sulfate (CS), we
stained sections of cultured lungs using a modified version of
Alcian blue (Heath, 1961). This technique shows strong stain-
ing in mesenchyme and basement membranes (Fig. 6B). Chon-
droitinase ABC pretreatment of sections followed by Alcian
blue showed that most of the mesenchymal staining disap-
pears, but strong signals remains in basement membrane (Fig.
6C, black arrow). Treatment with both heparinase III and
chondroitinase completely eliminates Alcian blue staining
(data not shown). This suggests that, during early branching,
most of the sulfated GAGs present in lungs represent chon-
droitin and heparan sulfate moieties.
We investigated the distribution of low-sulfated HS in
whole mounts and sections of E11.5 and E11.5  24 h-
cultured lungs by immunostaining with the 10E4 antibody.
10E4 recognizes relatively low O-sulfated, N-acetylated HS
epitopes (see Materials and methods; David et al., 1992).
Fig. 6D–H shows that 10E4 signals are predominantly ex-
pressed in the mesenchyme around distal tubules undergo-
ing branching morphogenesis. In E11.5 lung sections,
10E4-expressing cells are often found from subpleural to
the subepithelial mesenchyme but not in the epithelium
(Fig. 6G and H). No signals were observed in lungs pre-
treated with heparinase III (Fig. 6E) or without primary or
secondary antibodies (Fig. 6F).
Overall, the data suggest that the mesenchyme characteris-
tically expresses highly sulfated chondroitin sulfates and low-
sulfated HS, while most of the highly sulfated HS decorate
basement membranes of branching epithelial tubules.
HS are dynamically expressed in the mesenchyme at sites
of bud formation
To investigate the relationship between low-sulfated HS
(10E4 epitope) and bud formation, we performed whole-
mount immunohistochemistry of 10E4 and whole-mount in
situ hybridization of Fgf10 in mouse lungs during early
branching morphogenesis (E10–E13). Fgf10 is expressed in
areas of prospective budding (Bellusci et al., 1997). To
better capture 10E4 gradients, color development was kept
to a minimum so that areas of highest levels of expression
were highlighted. By comparing these expression patterns
in lungs at similar developmental stages, we found a re-
markable association between HS and Fgf10 signals in areas
of branching activity. This is exemplified in Fig. 7A (E10–
E10.5, caudal portions of both lungs) and D (E11.5, right
lung, medial, accessory, and caudal lobes), in which regions
expressing high levels of Fgf10 are also strongly stained
with 10E4. These signals were not colocalized at all sites
and times, which suggested that HS could be involved in
additional functions unrelated to FGF10. In some areas, the
domains of HS expression appear to broaden as buds elon-
gate (compare medial and accessory lobes at E11 and E11.5
in Fig. 7B and D, respectively). In other areas, the HS
pattern is stereotypical and highly dynamic, changing rap-
idly with the branching pattern. This is illustrated in Fig. 7C,
which depicts regional patterns of HS in left lungs that
differ in age by approximately 8 h; the specimens were
stained side by side to allow comparisons. See also changes
in HS in lateral portions of the caudal lobe from E11.5 (Fig.
7D) to E11.75 (Fig. 7E). The HS– Fgf10 association is less
clear in whole mounts after E13.
6-O-sulfotransferase expression in the distal lung
Although we could not detect a proximal–distal gradient
of Alcian blue staining along the basement membrane of
airways, we had functional evidence of increased synthesis
of O-sulfated GAGs at distal sites during branching (Fig. 2).
We asked whether O-sulfation could differentially occur in
proximal versus distal lung in branching airways. To ad-
dress this issue, we first identified expression of HS-modi-
fying enzymes HS 6-O-sulfotransferases (HS 6-OST) in
E11.5–E12 lung by RT-PCR (data not shown). Using
whole-mount in situ hybridization, we found that HS
6-OST1 is expressed throughout branching morphogenesis
predominantly in the distal epithelium (Fig. 8A). Analysis
of E11.25–E11.75 lungs shows that increasing levels appear
as the bud forms (Fig. 8B). Lower levels are diffusely
present in the mesenchyme; interestingly, the mesenchyme
at the tip of the accessory lobe is strongly labeled when
Fig. 7. Mesenchymal expression of heparan sulfate (HS, 10E4 immunostaining) and Fgf10 (in situ hybridization) during lung branching morphogenesis in
whole mounts. (A) Association between high levels of HS and Fgf10 signals in E10-E10.5 mouse lungs; (B) HS staining in emerging upper, medial, and
caudal lobes at E11; (C) dynamic pattern of HS in the left lung; note the rapid changes in the pattern of staining as new buds form (panels from left to right:
E11.25, E11.5, E11.75); (D) HS and Fgf10 signals in medial, caudal, and accessory lobe at E11.5; (E) HS pattern in lateral regions of the caudal lobe at E11.75
(compare with the pattern in the same area at E11.5 in Fig. 7D). Bars represent 120 m and 45 m in (B) and (D), respectively.
Fig. 8. Expression of HS 6-OST1 in developing mouse lung. (A) HS 6-OST1 is preferentially expressed in the distal epithelium of branching tubules (red
arrowhead) at E11.25–E14.5; diffuse weak signals are present in the mesenchyme; however, higher levels are found at the tip of the accessory lobe (blue
arrow in A) at E11.25. (B) Dynamic pattern of HS 6-OST1 in the left lung (from left to right: E11.25, E11.5, E11.75); asterisks (*) depict site of prospective
budding; signals (red arrowhead) increase as the bud forms. (C) Proximal (pr)-to-distal (di) gradient of HS 6-OST1 epithelial expression (top); expression
in the accessory lobe (bottom). Only background signals were obtained with sense probes (not shown). Ht, heart; lu, lung; li, liver.
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compared with other areas (blue arrows in Fig. 8B and C).
Our data suggest that the highly sulfated HS detected by
Alcian blue and 3G10 in basement membranes at distal sites
likely represents 6-O-sulfated HS. Further studies are in
course to determine expression pattern of other HS sulfo-
transferases.
Discussion
The goal of the present study was to understand the
mechanisms by which HS influences FGF10–FGFR2-me-
diated lung bud formation during branching morphogenesis.
Our data show developmentally regulated expression of HS
at sites of budding, with distinct patterns of HS sulfation in
the epithelial-associated basement membrane and mesen-
chyme. We have evidence that, in the epithelium, these
patterns are critical for local activation of FGF signaling by
FGF10 and induction of local budding. Our data suggest
that HS influence lung pattern formation by mechanisms
that include regulation of FGF10 protein distribution and
binding to its epithelial receptor.
We have identified rapidly changing gradients of HS low
in O-sulfated glycosaminoglycans in the mesenchyme at
sites where Fgf10 is highly expressed and epithelial buds
are forming. The dynamic pattern of HS expression suggests
that low O-sulfated HS may serve to facilitate diffusion and
direct FGF10 and possibly other distal signals from their
source to target cells. Indeed, the mechanism underlying
FGF2 transport through heparan sulfate-rich extracellular
matrix involves the dynamic reversible binding and disso-
ciation of FGF2 to and from HS sites (Dowd et al., 1999).
In this system, highly sulfated HS in basement membrane
reduce the rate of FGF2 movement through matrix by 100-
to 1000-fold compared with that observed when HS binding
was not allowed. Thus, decreased HS sulfation would result
in reduced binding affinity and dramatic acceleration of
growth factor movement through the matrix. In this way, the
low-sulfated HS in the mesenchyme could provide a con-
trolled source of FGF10, where interactions between FGF10
and HS are strong enough to maintain positional-specific
concentration gradients, yet weak enough to allow rapid
FGF10 movement to the epithelium. The epithelium, on the
other hand, with its more highly sulfated HS, could function
as an effective FGF10 sink by effectively competing with
the weaker binding sites in the mesenchyme.
A network of signaling molecules that includes FGF10,
Shh, its receptor Patched, and bone morphogenetic pro-
tein-4 (Bmp4) has been shown to be critical for distal lung
formation (reviewed in Hogan, 1999; Cardoso, 2001). HS
have been directly or indirectly implicated in regulating
localization or propagation of these molecules in a number
of developmental systems (reviewed in Perrimon and Bern-
field, 2000). The marked changes in lung pattern formation
observed in NaChl and over-O-sulfated-treated lung cul-
tures not only reflect the influence of HS on FGF10, but
likely also on other heparin binding signals, including the
above molecules. This suggests that some degree of O-
sulfation in HS expressed by the mesenchyme is necessary
to limit diffusion and to maintain these signals in their
proper place. In agreement with this, we found that HS
6-OST1 is also expressed in the mesenchyme at a lower
level and diffusely in areas weakly labeled by Alcian blue.
This is consistent with the idea that HS may help to delimit
morphogenetic boundaries in distal signaling centers of nas-
cent buds.
A study by Beer et al. (1997) supports the idea that HS
may be required to release FGF10 from its producing cell
and to protect it from proteolysis. It is conceivable that the
HS moiety detected by the 10E4 antibody in our study could
play a similar role in releasing FGF10 from mesenchymal
cells, preventing proteolysis, and allowing it to diffuse to
the epithelium. If such a mechanism exists in vivo, it likely
does not depend on levels of sulfation as high as those
present in heparin. The average low-sulfate content of the
10E4 epitope has been demonstrated by several studies
(David et al., 1992; Leteux et al., 2001).
Our data suggest that highly sulfated GAGs are present
in basement membranes and that 6-O-sulfated HS are dif-
ferentially expressed in distal epithelial tubules. A number
of studies implicate 6-O-sulfated HS as a major modulator
of FGF signaling in Drosophila tracheal development. Ex-
pression of Drosophila dHS6ST appears in cells that syn-
thesize the FGFRs breathless and heartless; RNAi inhibi-
tion of dHS6ST results in loss of FGF-dependent MAPK
activation and disruption of tracheal formation. (Kamimura
et al., 2001). Our study shows for the first time that there is
a proximal-to-distal gradient of HS 6-OST expression in the
developing lung with the highest levels at the tips. The
nearly absent expression in the proximal epithelium and our
functional assays suggest that the inability of these cells to
bind to and to respond to FGF10 may be related to the lack
of 6-O-sulfated GAGs.
We observed that, although activation of FGF10 signal-
ing can be achieved without HSPG, only activation in the
presence of appropriately sulfated heparan sulfate proteo-
glycans leads to epithelial survival and growth. As sug-
gested by several studies, HS help to form a stable complex
between growth factor and receptor to sustain signaling
(reviewed in Ornitz, 2000). It has been proposed that sul-
fated domains of HS moieties can dictate specificity of
FGF–FGFR binding; thus, signaling by the same FGFs via
different FGFRs can have distinct structural requirements
for HS (Ostrovsky et al., 2002). Here, we show that two
ligands with similar binding affinities for FGFR2b have
dramatically different requirements for HS and produce
different biological effects in the lung epithelium. Without
O-sulfated HS, FGF7- but not FGF10-treated epithelial cul-
tures survive. We found that it is possible to maintain
survival and reproduce the FGF7 effects on growth and
Bmp4 expression with FGF10 solely by providing exoge-
nous O-sulfated HS. Taken together, these results indicate
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that the ability of FGF10 to locally activate FGFR2b sig-
naling in the developing lung epithelium is largely depen-
dent on the profile of HS expressed by epithelial cells. Thus,
HS may function to fine tune the patterning events induced
by FGF10. The FGF10 requirement for specific pattern of
O-sulfation may be part of a mechanism that prevents wide-
spread activation of FGFR2b signaling in FGF-dependent
branching structures. Our data suggest that FGF7 is less
sensitive to this regulation by HS. Thus, it is not surprising
that FGF10 but not FGF7 is the critical FGFR2b ligand
present at the earliest stages of lung bud formation (Bellusci
et al., 1997; Park et al., 1998; Sekine et al., 1999). The basis
for the differences between FGF10 and FGF7 in HS require-
ment is still unclear and may be related to the ability of HS
to induce a stable conformation of the FGF10–FGFR2b
complex, comparable to that of an FGF7–FGFR2b complex.
It is conceivable that FGF10 interactions with HSPG trigger
unique intracellular signaling events leading to the forma-
tion of epithelial buds. Our assessment of MAPK and Akt
phosphorylation in FGF-treated 20-3 cells showed that nei-
ther of these pathways was differentially activated by
FGF10 or FGF7 under the conditions used.
In summary, our results lead us to propose a model (Fig.
9) in which HS interactions with FGF10 present in the distal
lung play a key role in branching morphogenesis. We pro-
pose that high levels of mesenchymal expression of HS low
in O-sulfated GAGs (10E4-reactive HS) in areas of pro-
spective budding may protect FGF10 from degradation and
sharpen the gradients of FGF10 diffusion to direct protein to
appropriate sites in the epithelium. At the basal lamina, in
association with the epithelium, HS with a high content of
sulfate groups or specific patterns of sulfation bind to
FGF10 and activate FGFR2b signaling. In the absence of
O-sulfated domains, FGF10 may not form a stable complex
with its receptor and signaling is not properly transduced.
Specific patterns of O-sulfation facilitate binding and
modulate activation of FGFR2b signaling in the distal epi-
thelium. 6-O-sulfated HS might be essential in this pro-
cess. Future studies aim at identifying specific HS structures
that are critical for FGF10–FGFR2b interactions in the
lung.
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